David Carney is a seasoned executive with extensive experience in healthcare technology and investment. Currently, Carney serves as Executive Chairman and Board Observer at OrbitalRX, which focuses on enhancing hospital pharmacy workflows amidst medication shortages. Additionally, Carney holds board positions at Nxtgen Care, Validic, and PrintReleaf, Inc., and is a member of the W.I.N. Wilmington Investor Network and Boston Hub Angels. Carney's past roles include being a member of the board of directors for Avhana Health and serving as a venture affiliate at Boston Millennia Partners, specializing in seed and early-stage investments in healthcare IT and SaaS companies. An MBA graduate from the University of Michigan's Stephen M. Ross School of Business and a BSE in Mechanical Engineering from the University of Michigan, Carney has also co-chaired the Digital Health & Sciences committee at Life Science Angels and advised Axial Exchange Inc.